Our imatinib results are congruent with previous studies in leukemia cells (Dong et al., 2018; Tu et al., 2018) and similarly, dasitinib also decreases p-STAT5 levels in BaF3/WT leukemia cells (Fiskus et al., 2006). This evidence concerns the gene STAT5A and leukemia.